Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial

Metabolism: Clinical and Experimental

Volumn 55, Issue 7, 2006, Pages 858-870

  Poretsky, Leonid ^a,d   Brillon, David J ^a   Ferrando, Stephen ^a   Chiu, Judy ^b   McElhiney, Martin ^b   Ferenczi, Andrea ^d   Sison, Maria Cristina Irene P ^e   Haller, Ivan ^a   Rabkin, Judith ^a,b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTRONE; GONADORELIN; PLACEBO; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; GONADAL STEROID HORMONES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN;

EID: 33745240025     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.02.013     Document Type: Article

References (67)

1. Labrie F., Belanger A., Simard J., et al. DHEA and peripheral androgen and estrogen formation: intracrinology. Ann N Y Acad Sci 774 (1995) 16-28
2. Orentreich N., Brind J.L., Rizer R.L., et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration throughout adulthood. J Clin Endocrinol Metab 59 (1984) 551-555
3. Jacobson M.A., Fusaro R., Galmarini M., et al. Decreased serum dehydroepiandrosterone is associated with an increased progression of HIV infection in men with CD4 cell counts 200-499. J Infect Dis 164 (1991) 864-868
4. Barrett-Connor E., von Muhlen D., Laughlin G., et al. Endogenous levels of DHEA sulfate; but not other sex hormones; are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc 47 (1999) 685-691
5. Yamada J., Zakuma M., and Suga T. Induction of peroxisomal beta-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochem Biophys Acta 1137 (1992) 231-235
6. Dillon J.S., Yaney G.C., Zhou Y., et al. Dehydroepiandrosterone sulfate and beta-cell function. Diabetes 49 (2000) 2012-2020
7. Solerte S.B., Fioravanti M., Vignati G., et al. Dehydroepiandrosterone sulfate enhances natural killer cell toxicity in humans via locally generated immunoreactive insulin-like growth factor I. J Clin Endocrinol Metab 84 (1999) 3260-3267
8. Williams M.R.I., Dawood T., Ling S., et al. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 89 (2004) 4708-4715
9. Khorram O., Vu L., and Yen S.S. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol Am Biol Sci Med 52 (1997) M1-M7
10. Lucas J.A., Ahmed S.A., Casey L.M., et al. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroepiandrosterone. J Clin Invest 75 (1985) 2091-2093
11. Danenberg H.D., Haring R., Heldman E., et al. Dehydroepiandrosterone enhances influenza immunization in aged mice. Ann N Y Acad Sci 774 (1995) 297-299
12. Schwartz A.G., and Pashko L.L. Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase. Ann N Y Acad Sci 774 (1995) 180-186
13. Yen T.T., Allan J.A., Pearson D.V., et al. Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids 12 (1977) 409-413
14. Van Vollenhoven R.F., Engleman E.G., and McGuire J.L. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind; placebo-controlled; randomized clinical trial. Arthritis Rheum 38 (1995) 1826-1831
15. Chang D.M., Lan J.L., Lin H.Y., and Luo S.F. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized; double-blind; placebo-controlled trial. Arthritis Rheum 46 (2002) 2924-2927
16. Rabkin J.G., Ferrando S.J., Wagner G.J., et al. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 25 (2000) 53-68
17. Casson P., Andersen R., Herrod H., Stentz F., Straughn A., Abraham G., et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169 (1993) 1536-1539
18. Villareal D.T., and Hollorzy J.O. Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA 292 (2004) 2243-2248
19. Kawano H., Yasue H., Kitagawa A., Hirai N., Yoshida T., Soejima H., et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 88 (2003) 3190-3195
20. Nestler J.E., Barlascini C.O., Clore J.N., et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66 (1988) 57-61
21. Mortola J.F., and Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71 (1990) 696-704
22. Kudielka B.M., Hellhammer J., and Hellhammer D.H. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of 2 week dehydroepiandrosterone treatment. J Clin Endocrinol Metab p3 (1998) 1756-1761
23. Morales A.J., Haubrich R.H., Hwang J.Y., et al. The effect of six month treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 49 (1998) 421-432
24. Morales A.J., Nolan J.J., Nelson J.C., and Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78 (1994) 1360-1367
25. Christeff N., Gharakhanian S., Thobie N., et al. Evidence for changes in adrenal and testicular steroids during HIV infection. Psychoneuroendorinology 22 Suppl 1 (1997) S11-S18
26. de la Torre B., von Krogh G., Svensson M., et al. Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels and CD4 T cell counts in HIV infection. Clin Exp Rheumatol 15 (1997) 87-90
27. Ferrando J.F., Rabkin J.G., and Poretsky L. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV disease illness stage and progression over one year. J Acquir Immune Defic Syndr 22 (1999) 146-154
28. Rabkin J.G., McElhiney M.C., Rabkin R., et al. DHEA effects on mild depression in HIV/AIDS: a placebo-controlled trial. Am J Psych 163 (2006) 59-66
29. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
30. First M.B., Pincus H.A., Frances A., and Widiger T.A. Diagnostic and statistical manual of mental disorders-fourth edition (DSM-IV) (1994), American Psychiatric Association, Washington (DC)
31. Matthews D.R., Hosker U.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
32. Soonthrornpun S., Setasuban W., Thamprasit A., Chayanunnukul W., Rattarasarn C., and Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 88 (2003) 1019-1023
33. Nestler J.E. DHEA: a coming of age. Ann N Y Acad Sci 774 (1995) ix-xi
34. Arnold J.T., and Blackman M.R. Does DHEA exert direct effects on androgen and estrogen receptors, and does it promote or prevent prostate cancer?. Endocrinology 146 (2005) 4565-4567
35. Kaiser J.D. Healing HIV: how to rebuild your immune system (1999), HealthFirst Press, Mill Valley (Calif) 170-180
36. Wolkowitz O.M., Reus V.I., Roberts E., Keebler A., Nelson N., Friedland M., et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychol 156 (1999) 646-649
37. Rabkin J.G., and Ferrando S.J. DHEA and HIV illness. AIDS Read 17 (1997) 29-38
38. Regelson W., and Kalimi M. Dehydroepiandrosterone (DHEA) the multifunctional steroid: effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action?. Ann N Y Acad Sci 719 (1994) 564-575
39. Dobs A.S., Dempsey M.A., Ladenson P.W., et al. Endocrine disorders in men infected with HIV. Am J Med 84 (1988) 611-616
40. Stolyarczyk R., Rubio S., Smolyar D., Young I., and Poretsky L. 24 hr urinary free cortisol in patients with acquired immune deficiency syndrome. Metabolism 47 (1998) 690-694
41. Poretsky L., Maran A., and Zumoff B. Endocrinological and metabolic manifestations of AIDS. Mt Sinai J Med 57 (1990) 236-241
42. Poretsky L., Can S., and Zumoff B. Testicular dysfunction in human immunodeficiency virus infected men. Metabolism 44 (1995) 946-953
43. Kratz A., Ferraro M., and Sluss P.M. Laboratory reference values. Case records of the Massachusetts General Hospital. N Engl J Med 351 (2004) 1548-1563
44. Christeff N., Lortholary O., Casassus P., et al. Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp Clin Endocrinol Diabetes 104 (1996) 30-136
45. Teichmann J., Stephan E., Lange U., et al. Evaluation of serum and urinary estrogen levels in male patients with HIV-infection. Eur J Med Res 3 (1998) 533-537
46. Membreno L., Irony I., Dere W., et al. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 65 (1987) 482-487
47. Rotterdam H., and Dembitzer F. The adrenal gland in AIDS. Endocr Pathol 4 (1993) 4-14
48. Morbiato G., and Bedilacqua M. Vagot: cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74 (1992) 608-613
49. Legrain S., Massien C., Lahlou N., et al. Dehydroepiandrosterone replacement administration: pharmacokinetics and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 85 (2000) 3208-3217
50. Arlt W., Callies F., Koehler I., et al. Dehydroepiandrosterone supplementation in healthy men with age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 86 (2001) 4686-4692
51. Arlt W., Haas J., Callies F., et al. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 84 (1999) 2170-2176
52. Arlt W., Cllies F., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 (1999) 1013-1020
53. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A.H., et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85 (2000) 4650-4656
54. Løvås K., Gebre-Medhin G., Trovik T.S., Fougner K.J., Uhlving S., Nedrebø B.G., et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88 (2003) 1112-1118
55. Callies F., Fassnacht M., van Vlijmen J.C., Koehler I., Huebler D., Seibel M.J., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 86 (2001) 1968-1972
56. Beer N.A., Jakubowitz D.J., Matt D.W., Beer R.M., and Nestler J.E. Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men. Am J Med Sci 311 (1996) 205-210
57. Kahn A.J., and Halloran B. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab 87 (2002) 1544-1549
58. Baulieu E.E., Thomas G., Legrain S., et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci U S A 97 (2000) 4279-4284
59. Johannsson G., Burman P., Wiren L., Engstrom B.E., Nilsson A.G., Ottosson M., et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo controlled trial. J Clin Endocrinol Metab 87 (2002) 2046-2052
60. Labrie F., Diamond P., Cusan L., Gomez J., Bélanger A., and Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82 (1997) 3498-3505
61. Barnhart K.T., Freeman E., Grisso J.A., Rader D.J., Sammel M., Kapoor S., et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84 (1999) 3896-3902
62. Grispoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
63. Gordon C.M., Grace E., Emans S.J., Feldman H.A., Goodman E., Becker K.A., et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87 (2002) 4935-4941
64. Smolyar D., Landman R., Poretsky L., et al. Comparison of 1 μg and 250 μg ACTH stimulation tests for the evaluation of adrenal function in patients with AIDS. Metabolism 52 (2003) 647-651
65. Poretsky L., Cataldo N., Rosenwaks Z., and Guidice L. Insulin-related ovarian regulatory system in health and disease. Endocr Rev 20 (1999) 535-582
66. Plymate S.R., Matej L.A., Jones R.E., and Friedl K.E. Inhibition of sex hormone-binding globulin production in the human hepatoma (HepG2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67 (1988) 460-464
67. Peiris A.N., Stagner J.L., Plymate S.R., Vogel R.L., Heck M., and Samols E. Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men. J Clin Endocrinol Metab 76 (1993) 279-282